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ABSTRACT
Objective: Depressive symptoms are common
following acute coronary syndrome (ACS) and predict
subsequent cardiovascular morbidity. Depression in
acute cardiac patients appears to be independent of
clinical disease severity and other cardiovascular
measures. One factor that has not been considered
previously is anaemia, which is associated with fatigue
and adverse cardiac outcomes. This study assessed
the relationship between anaemia on admission and
depressive symptoms following ACS.
Design: Longitudinal clinical observational study.
Setting: Coronary care unit.
Patients: 223 patients with documented ACS.
Main outcome measures: Depressive symptoms
measured with the Beck Depression Inventory 3 weeks
after admission.
Results: Anaemia was deﬁned with WHO criteria and
was present in 30 (13.5%) patients. Anaemia predicted
raised depression scores 3 weeks later independently
of age, gender, marital status, educational attainment,
smoking, Global Registry of Acute Cardiac Events
(GRACE) risk scores, negative mood in hospital and
history of depression (p¼0.003). The odds of a Beck
Depression Inventory score $10 among anaemic
patients were 4.03 (95% CIs 1.48 to 11.00), adjusted
for covariates. Sensitivity analyses indicated that
effects were also present when haemoglobin was
analysed as a continuous measure. Anaemia also
predicted major adverse cardiac events over the
subsequent 12 months.
Conclusions: Anaemia appears to contribute to
depression following ACS and is associated with future
cardiac morbidity. Studies evaluating the effects of
anaemia management will help delineate the role of
this pathway more precisely.
INTRODUCTION
Depression is common in the weeks following
an acute coronary syndrome (ACS), with
around 20% of patients fulﬁlling the criteria
for major depressive disorder, while
a substantial number report symptoms of
subclinical dysphoria.
1 Clinical depression
and depressed mood are predictors of future
cardiac mortality and morbidity,
2 and this has
led to intensive efforts to understand the
biology linking depression with coronary
heart disease (CHD) and to manage depres-
sion effectively.
One possibility is that depression following
ACS is related to the extent of underlying
coronary artery disease or to the severity of
the cardiac event. Although the evidence is
inconsistent,
3 an u m b e ro fs t u d i e sh a v e
demonstrated that depression among
cardiac patients is not related to left ejection
fraction, Killip class, previous myocardial
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ARTICLE SUMMARY
Article focus
- Depressive symptoms are common among
survivors of acute myocardial infarction and
other acute coronary syndromes (ACS) and
predict a poor long-term outcome.
- Depressive symptoms appear to be independent
of clinical disease severity.
- However, anaemia is common in ACS patients
and has not previously been examined as
a predictor of depressive symptoms.
Key messages
- Anaemia on admission with ACS predicted
depressive symptoms 3 weeks later, indepen-
dently of covariates.
- Anaemia also predicted major adverse cardiac
events over the next 12 months.
- Anaemia and haemoglobin levels should be
considered as biological determinants of depres-
sive symptoms following myocardial infarction
and other ACSs.
Strengths and limitations of this study
- This is the ﬁrst study to investigate anaemia and
subsequent depression in ACS patients using
a prospective design.
- The study was small scale and was not powered
to investigate the impact of depression on long-
term cardiac outcomes.
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Open Access Researchinfarction (MI) and other indices of disease severity.
45
The association between depression, future morbidity
and mortality has also been shown to be independent of
cardiovascular risk factors and aggregate measures of
post-MI risk such as the Global Registry of Acute
Cardiac Events (GRACE) risk score.
26Nevertheless,
other biological factors present during ACS that are
only weakly associated with the extent of underlying
coronary disease or severity of the cardiac event may be
relevant. Acute inﬂammation is one such mechanism,
7
but a factor that has received less attention is anaemia.
Anaemia is relatively common in acute cardiac patients,
with rates ranging from 12% to 16%.
8 9 An association
between anaemia on admission for ACS and adverse
cardiac outcomes is now well documented, with signiﬁ-
cant effects on 30-day and longer term mortality.
8e10
Anaemia is also associated with fatigue and impaired
quality of life in various patient groups,
11 12 and two
population studies of men and women aged 50 years and
over have documented positive relationships between
anaemia and depressive symptoms.
13 14 We therefore
tested the hypothesis that mild anaemia on admission
with an ACS would be associated with greater symptoms
of depression 3 weeks after the ACS and with the occur-
rence of major adverse cardiac events over the following
12 months. In these analyses, we also examined previous
history of depression and negative moods during hospi-
talisation in order to examine the possibility that anaemia
is related to longer standing depressed mood.
METHODS
Patients
Participants were 223 ACS patients admitted to St.
George’s Hospital in South London between June 2007
and October 2008 as part of a larger study of psychobi-
ological aspects of ACS.
15 Inclusion criteria were a diag-
nosis of ACS based on the presence of chest pain plus
veriﬁcation by diagnostic ECG changes, troponin T or
troponin I $99
th percentile of the upper reference limit.
Patients were required to be aged 18 years or over, not to
have comorbid conditions that might inﬂuence either
symptom presentation or mood and ability to complete
interviews and questionnaires in English. Patients with
severe anaemia (haematocrit <25%) were eligible for
blood transfusion and were excluded from the study.
16
Six hundred and sixty-six potentially eligible patients
were admitted on the days of recruitment. Of these, 125
patients (19%) had been discharged or transferred to
a different hospital before they could be recruited into
the study, 90 (14%) were too clinically fragile (eg, critical
ischaemia, ventricular tachyarrhythmia) to take part, 58
patients (9%) declined to participate, 75 (11%) did not
complete measures of depression 3 weeks after hospital-
isation, 27 (4%) could not speak English, 23 (3%) were
in confusional states, 7 (1%) patients died in hospital
and a further 38 (6%) were excluded for other reasons.
This study was approved by the Wandsworth Research
Ethics Committee, and written consent was obtained.
Clinical measures
Admission ECGs were reviewed for presentation as
ST elevation myocardial infarction (STEMI) or non-
STEMI/unstable angina (NSTEMI/UA). Cardiovascular
history and clinical factors during admission and
management were obtained from clinical notes and the
extent of signiﬁcant stenosis of coronary arteries from
angiography records. Clinical risk was assessed using the
GRACE risk score.
17 This uses nine indicators (age,
history of congestive heart failure, history of MI, systolic
blood pressure and heart rate on admission, STsegment
depression, initial serum creatinine, elevated cardiac
enzymes and in-hospital percutaneous coronary inter-
vention) to deﬁne risk of 6-month post-discharge death
applicable to all types of ACS. Creatine kinase was
measured in 210 patients. Anaemia on admission was
deﬁned according to WHO criteria as <13 g/dl for men
and <12 g/dl for women. Major adverse cardiac events
over the 12 months following ACS were deﬁned as
cardiovascular death, readmission with reinfarction or
UA, coronary artery bypass surgery or angioplasty.
Assessment of depressive symptoms
Patients were interviewed in their own homes an average
21.6 days following admission to hospital, and the Beck
Depression Inventory (BDI) was administered.
18 This
consists of 21 items rated on a scale of 0e3, so maximum
scores can range from 0 to 63. In addition to the stan-
dard scoring of the BDI, we also computed the somatic/
affective and cognitive/affective subscales identiﬁed by
de Jonge et al.
19 The somatic/affective subscale
comprised 13 items (eg, crying, irritability, fatigue,
pessimism), while the cognitive/affective subscale
included 12 items (eg, sense of failure, guilt, indeci-
siveness). The Cronbach’s a was 0.86 for the complete
scale and 0.80 and 0.83 for the somatic/affective and
cognitive/affective components, respectively. History of
depression was ascertained by interview.
Other measures
Patients’ emotional state in hospital was assessed with
a shortened version of the Proﬁle of Mood States, as
used previously.
20 Six high-loading items were taken
from each of the original Proﬁle of Mood States scales
(vigour, tensioneanxiety, depressionedejection, confu-
sion, angerehostility and fatigue). Current feelings on
each item were rated on a ﬁve-point scale ranging from
0 ¼ not at all to 4 ¼ extremely. Negative mood was indi-
cated by summarising the ﬁve negative scales. Socioeco-
nomic status was measured in terms of educational
attainment, and participants were classiﬁed on whether
they had secondary (high school) and college qualiﬁca-
tions or less than this (primary education only). Marital
and smoking status were assessed by self-report.
Statistical analysis
Comparisons between patients with and without
anaemia were made using t tests for continuous variables
and c
2 tests for categorical variables. The relationship
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Anaemia and depression following ACSbetween anaemia on hospital admission and depression
3 weeks later was assessed using analysis of covariance on
BDI scores, with age, gender, marital status, smoking,
educational attainment, GRACE risk score, negative
mood in hospital and history of depression as covariates.
These factors were included as covariates since they
could potentially be related both to anaemia and
elevated depressive symptoms, so confound any associa-
tion between the two. Similar methods were used to
analyse the association between anaemia and somatic
and cognitive symptoms of depression. Additionally, we
computed the proportion of patients with BDI scores
$10, the recognised threshold for possible depression.
Logistic regression computed the odds of elevated
depression in patients with anaemia compared with no
anaemia, and ORs with 95% CIs adjusted for the same
covariates were calculated. In order to test whether
associations depended on the diagnosis of anaemia or
persisted across the entire spectrum of haemoglobin
concentrations, linear regression of haemoglobin on
depression scores was also carried out. The association of
anaemia and future cardiac morbidity was investigated
by regressing anaemia onto major adverse cardiac events
recorded over the 12 months following ACS, controlling
for age, gender, marital status, smoking, educational
attainment, GRACE risk score, maximum creatine kinase
and history of depression.
RESULTS
Haemoglobin levels ranged from 8.3 to 19.0 g/dl, and 30
patients (13.5%) were deﬁned as anaemic according to
WHO criteria. There were no differences between the
anaemia and no anaemia groups in gender distribution,
age, ethnicity, educational attainment or marital status
(table 1). There were also no differences in history of
depression or in negative mood assessed during hospi-
talisation, though 30% of patients had a history of
depression. There was a tendency for GRACE risk scores
to be higher in patients with anaemia, but the differ-
ences were not signiﬁcant. However, creatine kinase
levels were lower among patients with anaemia
(p¼0.028). The groups did not differ in extent of
coronary disease, history of MI or in presentation with
STEMI or NSTEMI/UA. There were also no differences
in preadmission rates of diabetes (15.2%), hypertension
(44%) or raised cholesterol (74%). Percutaneous coro-
nary intervention was performed on 164 patients, 48
were managed medically and 11 were referred for
coronary artery bypass surgery. Treatment plans did not
differ in patients with and without anaemia.
Anaemia and depression following ACS
The mean score on the BDI measured 3 weeks following
admission for ACS was 6.7066.7, and 43 patients
(19.3%) had BDI scores $10. A small proportion (3.3%)
of patients were taking antidepressant medication. BDI
scores were signiﬁcantly higher in patients with anaemia
(mean 9.3568.7) than no anaemia (mean 6.2866.3)
after controlling for age and gender (p¼0.017), and the
difference was maintained after additional adjustment
for marital status, educational attainment, smoking,
GRACE risk score, negative mood in hospital and history
of depression (means 9.7368.7 and 6.2366.3, respec-
tively, p¼0.003). A higher proportion of patients with
anaemia had BDI scores $10 compared with the no
anaemia groups (33.3% and 17.1%, respectively), and
prescription of antidepressants tended to be higher in
patients with anaemia (10.7% vs 2.2%). The odds of
a high depression score in patients with anaemia were
4.03 (95% CI 1.48 to 11.00, p¼0.006) after adjustment
for age, gender, marital status, educational attainment,
smoking, GRACE risk score, negative mood and history
of depression (table 2). Other independent predictors
Table 1 Details of the study participants (mean6SD and N (%))
Anaemia (n[30) No anaemia (n[193) p Difference
Men 22 (73.3%) 166 (86.0%) 0.10
Women 8 (26.7%) 27 (14.0%)
Age (years) 61.70611.4 59.28611.7 0.29
Ethnicity (Caucasian) 27 (90.0%) 159 (82.4%) 0.43
Married 21 (70.0%) 139 (72.0) 0.83
Education (secondary and above) 15 (50.0%) 85 (44.3%) 0.45
Smoking 10 (33.3%) 75 (38.9%) 0.69
History of depression 11 (36.7%) 56 (29.0%) 0.40
Negative mood in hospital 3.1862.6 3.7662.8 0.69
GRACE score 97.67628.5 90.54626.0 0.17
Vessels with signiﬁcant stenosis 1.9760.55 1.8360.56 0.43
ACS type (STEMI) 25 (83.3%) 171 (88.6%) 0.88
Previous MI 6 (20.0%) 21 (10.9%) 0.22
CK level (IU/l)* 1209.96960 1806.461639 0.028
Haemoglobin (g/dl) 11.6761.15 14.8861.22 0.001
Haematocrit (%) 35.6463.9 42.6163.8 0.001
*n¼210, analysed following log transformation.
GRACE, Global Registry of Acute Cardiac Events; MI, myocardial infarction; STEMI, ST elevation myocardial infarction.
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Anaemia and depression following ACSin the model were negative mood in hospital (p<0.001)
and a positive history of depression (p¼0.049). Using
the more stringent criterion of a BDI score $16, the
adjusted odds of a high depression score in patients with
anaemia were similar (4.08, 95% CI 1.08 to 15.41,
p¼0.038). Additional statistical control for preadmission
disease burden (diabetes, hypertension), type of ACS or
for medication 3 weeks after admission did not change
these results.
The association between anaemia and depression
following ACS did not depend on the speciﬁc criterion
for anaemia utilised. When haemoglobin level was
regressed onto BDI score as a continuous variable, the
inverse association was signiﬁcant (B¼ 0.88, 95% CI
 1.42 to  0.33, p¼0.002), adjusting for the same cova-
riates (see table 3). We also tested whether the effect was
due to a preponderance of somatic symptoms of
depression in ACS patients with anaemia, by analysing
the somatic/affective and cognitive/affective subscales
of the BDI. In both cases, patients with anaemia had
elevated scores, although the effect was more robust for
somatic/affective (adjusted means 6.7965.7 and
4.6764.5 for anaemia and no anaemia groups, p¼0.026)
than cognitive/affective (adjusted means 4.0465.7 and
2.4863.8, p¼0.051) symptoms of depression. In case the
difference between patients with and without anaemia
was due to high scores on the two items on the BDI that
relate to sleep disturbance and fatigue (symptoms of
anaemia), we repeated the analyses with a reduced BDI
that omitted these items. The difference between
patients with and without anaemia remained signiﬁcant
(p¼0.010) after adjusting for age, gender, marital status,
educational attainment, smoking, GRACE risk score,
negative mood in hospital and history of depression.
Similarly, the regression of haemoglobin concentration
on the reduced BDI was replicated (B¼ 0.71, 95% CI
 1.15 to  0.26, p¼0.002).
In a further assessment of whether the elevated BDI
ratings of patients with anaemia were due to symptom
overlap, patients with and without anaemia were
compared on individual BDI items. In the fully adjusted
models, ratings on all items except for loss of appetite
were higher in patients with anaemia, with differences
signiﬁcant at p¼0.075 or less for eight items: sense of
failure, suicidal thoughts, crying, irritability, social with-
drawal, body image change, sleep problems and fatigue.
Anaemia and major adverse cardiac events
Thirty-four (15.2%) patients experienced a major
adverse cardiac event in the 12 months following ACS. A
higher proportion of adverse events occurred among
patients with anaemia than no anaemia on admission
(26.7% vs 13.5%). The odds of major adverse cardiac
events among patients with anaemia were 3.26 (CI 1.19
to 8.91, p¼0.021) after controlling for age, gender,
marital status, educational attainment, smoking, GRACE
risk score, negative mood in hospital, history of depres-
sion and creatine kinase levels in hospital. The study was
not powered to test the association between depressed
mood following ACS and adverse cardiac outcomes.
DISCUSSION
This study involved a relatively small sample of patients,
so conclusions must be tentative. Nevertheless, the
analyses indicated that mild-to-moderate anaemia
measured on admission to hospital with an ACS
predicted depression symptoms 3 weeks later. The mean
scores on the BDI were 48% higher in anaemic patients,
and the odds of a BDI score above the threshold for
moderate/severe depression ($10) were elevated
threefold. These associations were independent of socio-
demographic factors, clinical cardiological indices,
patients’ mood in hospital and history of dep-
ression. Anaemia in turn predicted major adverse
Table 2 Predictors of raised depressive symptom levels
3 weeks after ACS
Predictor Adjusted OR 95% CI p Value
Gender (men)* 0.65 0.21 to 1.97 0.44
Age 0.94 0.88 to 1.01 0.055
Education
(lowest)*
0.79 0.53 to 1.18 0.25
Marital status
(married)*
1.31 0.56 to 3.04 0.53
Smoking status
(non-smoker)*
1.09 0.48 to 2.49 0.84
GRACE score 1.01 0.99 to 1.04 0.39
Negative mood
in hospital
1.33 1.17 to 1.52 0.001
History of
depression
(negative)*
2.23 1.01 to 4.97 0.049
Anaemia
(no anaemia)*
4.03 1.48 to 11.00 0.006
*Reference category.
Table 3 Regression on depression symptoms 3 weeks
after ACS
Predictor
Regression
coefﬁcient B 95% CI p Value
Gender (men)*  0.44  2.98 to 2.11 0.74
Age  0.13  0.26 to 0.00 0.05
Education
(lowest)*
 0.42 01.22 to 0.39 0.31
Marital status
(married)*
1.31  0.53 to 3.15 0.16
Smoking status
(non-smoker)*
 0.41  1.78 to 1.70 0.96
GRACE score 0.02  0.04 to 0.08 0.68
Negative mood
in hospital
0.99 0.70 to 1.30 0.001
History of
depression
(negative)*
1.94 0.15 to 3.74 0.034
Haemoglobin  0.88  1.42 to  0.33 0.002
*Reference category.
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Anaemia and depression following ACScoronary events over the following 12 months, again
independently of socio-demographic and other clinical
characteristics.
The prevalence of anaemia was 13.5%, which is
comparable with that reported in other studies of older
adults. A recent systematic review concluded that the
prevalence of anaemia was 12% in community-based
studies,
21 suggesting that the levels in this sample of
cardiac patients were not notably elevated. Other studies
of acute cardiac patients have described rates between
12% and 17%.
81 01 6For example, around 13% of the
2082 patients with acute MI in the Controlled Abciximab
and Device Investigation to Lower Late Angioplasty
Complications (CADILLAC) trial were anaemic.
9 The
mean level of haemoglobin (11.67 g/dl) indicates that
anaemia was typically mild, and none of the patients had
haematocrit levels <25%, the currently accepted
threshold for blood transfusion.
16 Several different
criteria for anaemia have been proposed, and slightly
higher haemoglobin thresholds were recommended by
Beutler and Waalen.
22 Our sensitivity analysis indicated
that the relationship with depression following ACS
did not depend on the particular threshold selected
since effects were continuous across the haemoglobin
distribution.
We tested four sets of factors that could theoretically
contribute to the association between anaemia and
depression following ACS. First, both anaemia and
depression are associated with lower socioeconomic
status and ethnic minority status,
23 so socio-demo-
graphic factors could be relevant. We found no differ-
ences in the occurrence of anaemia in relation to ethnic
minority status and controlled statistically for educa-
tional attainment as a marker of socioeconomic status.
Second, poor clinical cardiological status is associated
with anaemia
10 and might also predict depression
following ACS. GRACE risk scores were included to take
cardiological status into account since this risk index
includes potentially relevant factors such as presence of
heart failure and previous MI. Additional analyses
showed that the relationship between anaemia and
depression was also independent of other clinical indi-
cators such as type of ACS and preadmission illness
burden. Third, it is possible that anaemia is associated
with depressed mood irrespective of the occurrence of
ACS
13 14 and that the relationship with depression
following ACS reﬂects more persistent effects. The
impact of pre-existing depressed mood cannot be
completely ruled out since the BDI was not administered
on admission and depression before ACS was measured
retrospectively. We did not ask patients to complete the
BDI when they were in hospital since we thought that
patients might ﬁnd it difﬁcult to recollect their symp-
toms before hospitalisation and rate them accurately.
However, we reasoned that if prevailing depression was
responsible for the association between anaemia and
later depressive symptoms, differences between patients
with and without anaemia would have been apparent in
history of depression or in negative moods assessed in
hospital. This was not the case, suggesting that anaemia
has a speciﬁc impact on depressive symptoms that evolve
after an acute cardiac event.
A fourth possibility is that the association was due to
symptom overlap since the BDI includes non-speciﬁc
symptoms that may be indications of anaemia. For
example, anaemia has previously been related to fatigue
in various illnesses including cancer, heart failure and
chronic lung disease.
11 12 24 We tested this notion in
a several ways. When we constructed a reduced version of
the BDI that excluded items related to fatigue and sleep
disturbance, differences between patients with and
without anaemia persisted. We also conjectured that
anaemia might be associated more strongly with somatic
symptoms of depression such as fatigue, loss of appetite
and insomnia than with cognitive/affective symptoms
such as guilt and sense of failure. However, both
components of the BDI identiﬁed by de Jonge et al
19 were
elevated in the patients with anaemia. Finally, inspection
of individual items from the BDI indicated that anaemic
and non-anaemic patients showed differential responses
on a number of cognitive symptoms such as sense of
failure, social withdrawal and irritability as well as more
somatic items such as tiredness and sleep problems. In
combination, these tests suggest that symptom overlap is
unlikely to be the explanation of the ﬁndings.
Anaemia on hospitalisation was a predictor of major
adverse cardiac events over the subsequent 12-month
period, replicating ﬁndings from larger studies.
8e10 The
study was not powered to test the impact of depression
following ACS on cardiac mortality and morbidity.
Previous reviews of this topic have criticised the publi-
cation of equivocal ﬁndings from underpowered
studies.
25 We were not therefore able to investigate the
extent to which the presence of anaemia in some
patients with depression following ACS contributes to
the association between depression and future cardiac
morbidity.
It has been estimated that around one-third of
anaemia in older people is due to blood loss or nutri-
tional deﬁciencies, one-third to chronic diseases
involving inﬂammation, while the remaining one-third is
unexplained.
26 The contribution of nutritional deﬁ-
ciencies in this sample is unknown, and measures of
iron-restricted haematopoiesis were not carried out.
Inﬂammatory processes may be relevant since acute
inﬂammation during ACS has been postulated to be
a cause of subsequent depressed mood.
7 Possible causes
of unexplained anaemia that are potentially relevant to
these ﬁndings include sarcopenia, more subtle dysregu-
lation of the immune system and the impact of some
medications.
27
A number of processes may be involved in mediating
the effects of anaemia on cardiovascular risk. The
reduction in haemoglobin concentration can adversely
affect oxygen supply to the myocardium, promoting
arrhythmia and increasing infarct size.
26 At the same
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Anaemia and depression following ACStime, anaemia leads to increased myocardial oxygen
demand though stimulating raised cardiac output
28 and
may have an effect on nitric oxide bioavailability.
29 The
impact of anaemia on future depressed mood may be
due in part to reduced physical performance and
strength which will impair physical activity during
recovery from ACS.
30 Decreased physical activity may in
turn enhance depressed mood. Dyspnoea is also charac-
teristic of anaemia and could reduce physical and social
activity, promoting depressed mood following ACS.
This study has a number of limitations. As noted
earlier, the sample size was insufﬁcient to investigate the
impact of depressive symptoms following ACS on
subsequent adverse cardiac outcomes, so the importance
of anaemia in mediating such links was not tested. We
had no measure of depressive symptoms in the days
preceding the index cardiac event, so cannot deﬁnitively
rule out an association between anaemia and pre-
existing depression. The somatic/affective and cogni-
tive/affective subscales of the BDI used in this study were
based on previous work
19 but were empirically derived
and do not precisely separate somatic from affective
components. Additionally, although our conclusion is
that anaemia may have a speciﬁc effect on depressive
symptoms that evolve after an acute cardiac event, we
cannot rule out the possibility that its impact generalises
to the aftermath of other stressors.
Studies relating depression following ACS with subse-
quent cardiac morbidity and mortality have assessed
a number of indices of cardiac status and other physical
health issues using the GRACE index, Killip class and
measures of comorbidity such as the Charlson index.
6 19
But to our knowledge, the relationship between anaemia
and depression following ACS has not been investigated
in previous research. The present ﬁndings indicate that
attention needs to be paid in larger studies in the future
to anaemia as a possible contributor to depression
following acute cardiac events and as a determinant of
future cardiac morbidity. Studies evaluating the effects of
anaemia management on depression following ACS will
help delineate the role of this pathway more precisely.
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